A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer

NCT04677504 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Biliary Tract Cancer

Interventions

DRUG: Atezolizumab
DRUG: Bevacizumab
OTHER: Placebo
DRUG: Cisplatin
DRUG: Gemcitabine

Sponsor

Hoffmann-La Roche